prescriber.org.uk-prescribing advice for gps - an nhs prescribing advisers' blog

Technical data of the prescriber.org.uk

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host prescriber.org.uk. Currently, hosted in United States and its service provider is E.I. du Pont de Nemours and Co. Inc. .

Latitude:	39.749801635742
Longitude:	-75.554298400879
Country:	United States (US)
City:	Wilmington
Region:	Delaware
ISP:	E.I. du Pont de Nemours and Co. Inc.

the related websites

nurseprescriberforum.co.uk

strath.ac.uk

practicenursing.co.uk

telegraph.co.uk

fasciadirect.co.uk

behaviouralinsights.co.uk

projectsmart.co.uk

hscic.gov.uk

stonewall.org.uk

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.

X-Xss-Protection:	1; mode=block
Content-Security-Policy:	default-src 'self' https:; child-src 'self' https: https://platform.twitter.com; script-src 'self' https: 'unsafe-inline'; style-src 'self' https: 'unsafe-inline' ; font-src 'self' https: data:; img-src 'self' https: data:; report-uri https://www.prescriber.org.uk/csp-report.php
X-Content-Type-Options:	nosniff
Content-Encoding:	gzip
Transfer-Encoding:	chunked
Set-Cookie:	wordpress_01a6523d5fd06cf089a1a90026de7a84=+; expires=Fri, 28-Jul-2017 12:49:47 GMT; Max-Age=0; path=/wp-admin, wordpress_sec_01a6523d5fd06cf089a1a90026de7a84=+; expires=Fri, 28-Jul-2017 12:49:47 GMT; Max-Age=0; path=/wp-admin, wordpress_01a6523d5fd06cf089a1a90026de7a84=+; expires=Fri, 28-Jul-2017 12:49:47 GMT; Max-Age=0; path=/wp-content/plugins, wordpress_sec_01a6523d5fd06cf089a1a90026de7a84=+; expires=Fri, 28-Jul-2017 12:49:47 GMT; Max-Age=0; path=/wp-content/plugins, wordpress_logged_in_01a6523d5fd06cf089a1a90026de7a84=+; expires=Fri, 28-Jul-2017 12:49:47 GMT; Max-Age=0; path=/, wordpress_logged_in_01a6523d5fd06cf089a1a90026de7a84=+; expires=Fri, 28-Jul-2017 12:49:47 GMT; Max-Age=0; path=/, wp-settings-0=+; expires=Fri, 28-Jul-2017 12:49:47 GMT; Max-Age=0; path=/, wp-settings-time-0=+; expires=Fri, 28-Jul-2017 12:49:47 GMT; Max-Age=0; path=/, wordpress_01a6523d5fd06cf089a1a90026de7a84=+; expires=Fri, 28-Jul-2017 12:49:47 GMT; Max-Age=0; path=/, wordpress_01a6523d5fd06cf089a1a90026de7a84=+; expires=Fri, 28-Jul-2017 12:49:47 GMT; Max-Age=0; path=/, wordpress_sec_01a6523d5fd06cf089a1a90026de7a84=+; expires=Fri, 28-Jul-2017 12:49:47 GMT; Max-Age=0; path=/, wordpress_sec_01a6523d5fd06cf089a1a90026de7a84=+; expires=Fri, 28-Jul-2017 12:49:47 GMT; Max-Age=0; path=/, wordpressuser_01a6523d5fd06cf089a1a90026de7a84=+; expires=Fri, 28-Jul-2017 12:49:47 GMT; Max-Age=0; path=/, wordpresspass_01a6523d5fd06cf089a1a90026de7a84=+; expires=Fri, 28-Jul-2017 12:49:47 GMT; Max-Age=0; path=/, wordpressuser_01a6523d5fd06cf089a1a90026de7a84=+; expires=Fri, 28-Jul-2017 12:49:47 GMT; Max-Age=0; path=/, wordpresspass_01a6523d5fd06cf089a1a90026de7a84=+; expires=Fri, 28-Jul-2017 12:49:47 GMT; Max-Age=0; path=/, wp-postpass_01a6523d5fd06cf089a1a90026de7a84=+; expires=Fri, 28-Jul-2017 12:49:47 GMT; Max-Age=0; path=/
Strict-Transport-Security:	max-age=31536000; includeSubDomains
Vary:	Accept-Encoding
X-Hyper-Cache:	stop - mobile
Server:	Apache
Connection:	close
Date:	Sat, 28 Jul 2018 12:49:47 GMT
X-Frame-Options:	ALLOW-FROM www.prescriber.org.uk platform.twitter.com
Referrer-Policy:	no-referrer
Content-Type:	text/html; charset=UTF-8
Public-Key-Pins:	pin-sha256="vMHJ3rV7aDh8alMD5tOy+w/K5YZpyszss2JFQNEFiBE="; max-age=10;

DNS

soa:	dns1.bcs-hosting.net. info.broadbandcloudsolutions.co.uk. 2017110100 3600 7200 1209600 86400
txt:	"v=spf1 +a +mx +ip4:52.56.185.44 ~all"
ns:	dns1.bcs-hosting.net. dns2.bcs-hosting.net.
ipv4:	IP:52.56.185.44 ASN:16509 OWNER:AMAZON-02 - Amazon.com, Inc., US Country:US
mx:	MX preference = 0, mail exchanger = prescriber.org.uk.

HtmlToText

prescribing advice for gps an nhs prescribing advisers' blog home free subscriptions about contact resources privacy policy benzodiazepine converter hba1c conversions inhaler table drug safety update - july 2018 july 19, 2018 at 9:33 am | in prescribing extra - drugs | print | no comments the medicines and healthcare products regulatory agency (mhra) has published drug safety update for july 2018 ( pdf ). this issue advises of the risk of airway obstruction from aspiration of loose objects when using pressurised metered dose inhalers (pmdi). there have been 22 reports in the uk of accidental inhalation of the mouthpiece cover or objects that have become trapped in the inhaler since 1987 with a further 36 cases reported outside of the uk. it is suggested that patients using pmdi inhalers are advised to: store the inhaler with the mouthpiece cover correctly in place remove the mouthpiece fully before using the inhaler shake the inhaler to remove loose objects that may not be visible before use check the inside and outside of the mouthpiece are clear before inhaling a dose not use damaged inhalers yellow cards should be submitted to report adverse incidents during use of inhalers and are also invited in this issue for suspected adverse reactions associated with medicines taken during pregnancy experienced by women or the baby or child . action: clinicians should be aware of this month's new guidance and implement any necessary changes to practice. copyright © 2005-2018 prescribing advice for gps -- nice guidance - july 2018 july 18, 2018 at 12:24 pm | in prescribing extra - other | print | no comments the national institute of health and care excellence (nice) have published new or updated guidance for the month of july 2018. this month there is one guideline that impacts upon primary care. the rheumatoid arthritis in adults guideline has been published, it updates and replaces existing guidance. it covers diagnosing and managing rheumatoid arthritis. it aims to improve quality of life by ensuring that people with rheumatoid arthritis have the right treatment to slow the progression of their condition and control their symptoms. people should also have rapid access to specialist care if their condition suddenly worsens. action: clinicians should be aware of this month's new guidance and implement any necessary changes to practice. copyright © 2005-2018 prescribing advice for gps -- cks updates - june 2018 july 2, 2018 at 2:03 pm | in prescribing extra - other | print | no comments during june 2018 clinical knowledge summaries were published or updated in the following areas. new topics were published for: cirrhosis faltering growth the following topics were all reviewed : anaemia - iron deficiency attention deficit hyperactivity disorder fungal skin infection - foot miscarriage vaginal discharge the majority of topics have undergone reviews and minor restructures. the most significant changes were to the fungal skin infection - foot topic which has had complications and differential diagnosis nodes added. management recommendations have been updated in line with the current literature and the prescribing information section has been updated and expanded. action: clinicians who see patients with any of these conditions may find the new and updated information useful when reviewing current clinical practice . copyright © 2005-2018 prescribing advice for gps -- drug safety update - june 2018 june 25, 2018 at 1:09 pm | in prescribing extra - drugs | print | no comments the medicines and healthcare products regulatory agency (mhra) has published drug safety update for june 2018 ( pdf ). this issue advises that there is an increased risk of neural tube defects in women who become pregnant while taking dolutegravir for the treatment of hiv . if pregnancy is confirmed in the first trimester their specialist should consider switching to an alternative treatment. this issue also notifies readers of two emerging concerns regarding denosumab ( xgeva ® ▼). rebound hypercalcaemia have been reported up to 9 months after discontinuation of denosumab. periodic monitoring of serum calcium is recommended. a pooled analysis has also shown an increased incidence of new primary malignancies in patients treated with denosumab compared to zoledronic acid. all suspected adverse reactions for denosumab should be reported , including any new primary malignancies. finally this month, the summary of letters to healthcare professionals includes a reminder of false readings seen with certain batches of accu-chek test strips , as reported last month . action: clinicians should be aware of this month's new guidance and implement any necessary changes to practice. copyright © 2005-2018 prescribing advice for gps -- nice guidance - june 2018 june 20, 2018 at 9:26 am | in prescribing extra - other | print | no comments the national institute of health and care excellence (nice) have published new or updated guidance for the month of june 2018. this month there is one guideline and one technology appraisal that impact upon primary care. the dementia guideline has been published . it replaces a previous guideline from 2006 and covers diagnosing and managing dementia (including alzheimer's disease). it aims to improve care by making recommendations on training staff and helping carers to support people living with dementia. the donepezil, galantamine, rivastigmine and memantine for the treatment of alzheimer's disease technology appraisal has been updated with the recommendations in section 1.3 replaced by the guideline above. action: clinicians should be aware of this month's new guidance and implement any necessary changes to practice. copyright © 2005-2018 prescribing advice for gps -- « older posts author this blog is maintained by matthew robinson . quicksearch search term: subscribe to email notifications leave this blank: leave this blank too: do not change this: your email: follow on twitter follow @pa4gps categories admin information (21) critical appraisal tips (15) prescribing bulletin (3) prescribing extra - drugs (755) prescribing extra - other (704) prescribing formulary (12) archives 2018 january february march april may june july 2017 january february march april may june july august september october november december 2016 january february march april may june july august september october november december 2015 january february march april may june july august september october november december 2014 january february march april may june july august september october november december 2013 january february march april may june july august september october november december 2012 january february march april may june july august september october november december 2011 january february march april may june july august september october november december 2010 january february march april may june july august september october november december 2009 january february march april may june july august september october november december 2008 january february march april may june july august september october november december 2007 january february march april may june july august september october november december 2006 january february march april may june july august september october november december 2005 june july august september october november december links journals annals of internal medicine bmj cmaj jama jama internal medicine lancet nejm plos medicine prescrire (in english) links ash bandolier bbc health news bmj learning bnf bnf for children bsa information services portal bumps care quality commission clinical evidence clinical knowledge summaries cochrane library department of health dermnet nz drug tariff dtb emims european medicines agency eyes on evidence fit for travel food and drug interactions green book health protection agency healthcare events hiv drug interactions lab tests online lancashire mmg medical research council medicines and prescribing centr

URL analysis for prescriber.org.uk

http://api.addthis.com/oexchange/0.8/forward/delicious/offer?url=https://www.prescriber.org.uk/2018/06/nice-guidance-june-2018/&title=nice+guidance+-+june+2018
https://www.prescriber.org.uk/2018/06/nice-guidance-june-2018/#respond
http://api.addthis.com/oexchange/0.8/forward/digg/offer?url=https://www.prescriber.org.uk/2018/07/cks-updates-june-2018/&title=cks+updates+-+june+2018
https://www.prescriber.org.uk/2018/04/
https://www.prescriber.org.uk/2010/06/
https://www.prescriber.org.uk/2013/10/
http://api.addthis.com/oexchange/0.8/forward/twitter/offer?url=https://www.prescriber.org.uk/?p=1510&title=nice+guidance+-+june+2018
http://api.addthis.com/oexchange/0.8/forward/google_plusone_share/offer?url=https://www.prescriber.org.uk/2018/06/drug-safety-update-june-2018/&title=drug+safety+update+-+june+2018
https://www.prescriber.org.uk/2017/07/
https://www.prescriber.org.uk/2009/03/
https://www.prescriber.org.uk/2014/04/
http://api.addthis.com/oexchange/0.8/forward/stumbleupon/offer?url=https://www.prescriber.org.uk/2018/07/drug-safety-update-july-2018/&title=drug+safety+update+-+july+2018
https://www.prescriber.org.uk/2005/
http://validator.w3.org/check?uri=https://www.prescriber.org.uk
https://www.prescriber.org.uk/2016/04/
foodanddruginteractions.co.uk
news.bbc.co.uk
evidence.nhs.uk
hpa.org.uk
medslearning.leeds.ac.uk
medicines.org.uk
patient.co.uk
ppa.org.uk
whyaande.nhs.uk
cks.nice.org.uk

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Error for "prescriber.org.uk".

the WHOIS query quota for 2600:3c03:0000:0000:f03c:91ff:feae:779d has been exceeded
and will be replenished in 61 seconds

WHOIS lookup made at 06:06:26 09-Oct-2017

--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:

Copyright Nominet UK 1996 - 2017.

You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REFERRER http://www.nominet.org.uk

  REGISTRAR Nominet UK

SERVERS

  SERVER uk.whois-servers.net

  ARGS prescriber.org.uk

  PORT 43

  TYPE domain

DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REGISTERED no

DOMAIN

  NAME prescriber.org.uk

NSERVER

  DNS1.BCS-HOSTING.NET 52.56.192.45

  DNS2.BCS-HOSTING.NET 52.31.211.142

Go to top

prescriber.org.uk Report : Visit Site